Ming Tan

Hivatkozott rá

	Összes	2020 óta
Hivatkozások	27254	9907
h-index	56	35
i10-index	91	77

2400

1200

600

1800

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202577 95 85 105 116 120 243 289 378 426 552 660 766 922 1194 1475 1658 1938 2028 1965 2042 2159 2343 1831 1615 1698 256

Nyilvános hozzáférés

Összes megtekintése

61 cikk

4 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

Oystein fodstadProfessor emeritus, Oslo University Hospital, University of OsloE-mail megerősítve itt: rr-research.no
Jianrong LuUniversity of FloridaE-mail megerősítve itt: ufl.edu
Jingshan HuangUniversity of South AlabamaE-mail megerősítve itt: southalabama.edu
Clayton YatesJohns Hopkins School of MedicineE-mail megerősítve itt: jhmi.edu
Erin Eunyoung AhnUniversity of Alabama at BirminghamE-mail megerősítve itt: uabmc.edu
Francisco J. EstevaChief, Breast Medical Oncology, Northwell Health Cancer Institute at Lenox Hill HospitalE-mail megerősítve itt: northwell.edu
Aysegul SahinMD Anderson Cancer CenterE-mail megerősítve itt: mdanderson.org
Bolin LiuLSUHSCE-mail megerősítve itt: lsuhsc.edu
Glen BorchertProfessor of Pharmacology, University of South Alabama COME-mail megerősítve itt: southalabama.edu
Ssang-Taek Steve LimUniversity of Alabama at BirminghamE-mail megerősítve itt: uabmc.edu
Caroline E. Nunes XavierInstitute for Cancer Research, Oslo University Hospital. Biobizkaia Health Research InstituteE-mail megerősítve itt: rr-research.no
Khanisyah Erza GumilarObsteric and Gynecology Airlangga University HospitalE-mail megerősítve itt: fk.unair.ac.id
Binhua P ZhouProfessor, UK College of MedicineE-mail megerősítve itt: uky.edu
Jung-Hyun KimNational Cancer CenterE-mail megerősítve itt: ncc.re.kr
Gary Anthony PiazzaEndowed Professor and Department HeadE-mail megerősítve itt: auburn.edu
Robert W. Sobol, PhDDepartment of Pathology and Laboratory Medicine & Legorreta Cancer Center at Brown UniversityE-mail megerősítve itt: brown.edu
Daniel J. KlionskyUniversity of MichiganE-mail megerősítve itt: umich.edu
Shi-yuan ChengNorthwestern UniversityE-mail megerősítve itt: northwestern.edu
Cristina Muñoz-PinedoPreclinical and Experimental Research in Thoracic Cancer - Oncobell Program - IDIBELL (Institut dE-mail megerősítve itt: idibell.cat
Elizabeth R. WrightProfessor, University of Wisconsin - MadisonE-mail megerősítve itt: wisc.edu

Követés

Ming Tan

China Medical University, Taiwan

E-mail megerősítve itt: mail.cmu.edu.tw - Kezdőlap

Cancer Biology Cancer Metabolism Cell Death Signal Transduction microRNA


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd Edition) DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... Autophagy 12 (1), 1-222, 2016	12268*	2016
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Y Nagata, KH Lan, X Zhou, M Tan, FJ Esteva, AA Sahin, KS Klos, P Li, ... Cancer Cell 6 (2), 117-127, 2004	2289	2004
Targeting cellular metabolism to improve cancer therapeutics. Y Zhao, E Butler, M Tan Cell Death & Disease, 4, e532; doi:10.1038/cddis.2013.60, 2013	1210	2013
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism J Lu, M Tan, Q Cai Cancer Letters, 2014	775	2014
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis YM Li, Y Pan, Y Wei, X Cheng, BP Zhou, M Tan, X Zhou, W Xia, ... Cancer Cell 6 (5), 459-469, 2004	694	2004
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression M Zhou, Z Liu, Y Zhao, Y Ding, H Liu, Y Xi, W Xiong, G Li, J Lu, O Fodstad, ... Journal of Biological Chemistry 285 (28), 21496-21507, 2010	502	2010
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers X Zhou, M Tan, VS Hawthorne, KS Klos, KH Lan, Y Yang, W Yang, ... Clinical Cancer Research 10 (20), 6779-6788, 2004	477	2004
Overexpression of ErbB2 Blocks Taxol-Induced Apoptosis by Upregulation of p21Cip1, which Inhibits p34Cdc2 Kinase D Yu, T Jing, B Liu, J Yao, M Tan, TJ McDonnell, MC Hung Molecular Cell 2 (5), 581-591, 1998	472	1998
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol M Zhou, Y Zhao, Y Ding, H Liu, Z Liu, O Fodstad, AI Riker, ... Molecular cancer 9, 1-12, 2010	441	2010
Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism A Angajala, S Lim, JB Phillips, JH Kim, C Yates, Z You, M Tan Frontiers in immunology 9, 1605, 2018	421	2018
The role of ChatGPT in scientific communication: writing better scientific review articles J Huang, M Tan American journal of cancer research 13 (4), 1148, 2023	345	2023
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities M Tan, J Yao, D Yu Cancer Research 57 (6), 1199-1205, 1997	337	1997
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism Y Zhao, H Liu, Z Liu, Y Ding, SP LeDoux, GL Wilson, R Voellmy, Y Lin, ... Cancer Research 71 (13), 4585-4597, 2011	327	2011
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth YH Zhao, M Zhou, H Liu, Y Ding, HT Khong, D Yu, O Fodstad, M Tan Oncogene 28 (42), 3689-3701, 2009	296	2009
Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. D Yu, B Liu, M Tan, J Li, SS Wang, MC Hung Oncogene 13 (6), 1359-1365, 1996	292	1996
The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy Y Fu, S Liu, S Yin, W Niu, W Xiong, M Tan, G Li, M Zhou Oncotarget 8 (34), 57813, 2017	274	2017
Glucose oxidation modulates anoikis and tumor metastasis S Kamarajugadda, L Stemboroski, Q Cai, NE Simpson, S Nayak, M Tan, ... Molecular and cellular biology 32 (10), 1893-1907, 2012	254	2012
Molecular mechanisms of erbB2-mediated breast cancer chemoresistance M Tan, D Yu Breast Cancer Chemosensitivity, 119-129, 2007	236	2007
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous … KS Klos, SL Wyszomierski, M Sun, M Tan, X Zhou, P Li, W Yang, G Yin, ... Cancer Research 66 (4), 2028-2037, 2006	228	2006
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification VY Chung, TZ Tan, M Tan, MK Wong, KT Kuay, Z Yang, J Ye, J Muller, ... Scientific reports 6 (1), 19943, 2016	173	2016

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők